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Acidification of the extracellular and/or intracellular environment is involved in many aspects of cell physiology and pathology.
Eukaryotic elongation factor 2 kinase (eEF2K) is a Ca2/calmodulin-dependent kinase that regulates translation elongation by
phosphorylating and inhibiting eEF2. Here we show that extracellular acidosis elicits activation of eEF2K in vivo, leading to en-
hanced phosphorylation of eEF2.We identify five histidine residues in eEF2K that are crucial for the activation of eEF2K during
acidosis. Three of them (H80, H87, and H94) are in its calmodulin-binding site, and their protonation appears to enhance the
ability of calmodulin to activate eEF2K. The other two histidines (H227 and H230) lie in the catalytic domain of eEF2K.We also
identify His108 in calmodulin as essential for activation of eEF2K. Acidification of cancer cell microenvironments is a hallmark
of malignant solid tumors. Knocking down eEF2K in cancer cells attenuated the decrease in global protein synthesis when cells
were cultured at acidic pH. Importantly, activation of eEF2K is linked to cancer cell survival under acidic conditions. Inhibition
of eEF2K promotes cancer cell death under acidosis.
Acidification is implicated in physiological and pathologicalprocesses, including high-intensity exercise (1), diabetic ke-
toacidosis, and ischemia (2), and in solid tumors (3). Acidosis is
associated with conditions of increased energy demand or en-
hanced flux through anaerobic glycolysis; therefore, under acido-
sis, cells require a mechanism that turns off processes such as
protein synthesis, which has a very high demand for energy (4),
under conditions such as hypoxia and energy shortage (5, 6). In
addition, low extracellular pH (usually pH 6.5 to 6.9, may reach
pH 6.2) is a hallmark of malignant solid tumors. Acidic tumor
microenvironments drive cancer cell invasion (7) and boost ag-
gressiveness by promoting angiogenesis and impeding immune
rejection (3). Acidosis is cytotoxic to normal tissues and causes
both apoptotic and necrotic cell death, yet cancer cells can resist
acidic conditions (8). However, the exact survival mechanism(s)
remains poorly understood.
Another unanswered question is “how do cells turn off protein
synthesis in response to acidosis?” Previously, it has been shown
that activation of mammalian target of rapamycin (mTOR) com-
plex 1 (mTORC1), which controls anabolic processes, including
mRNA translation (9), is acutely inhibited by extracellular acido-
sis (5). mTORC1 can be positively regulated by many signals via
the tuberous sclerosis 1 and 2 (TSC1/2) complex, a GTPase acti-
vator protein for the small G protein Rheb (10). GTP-boundRheb
activatesmTORC1. The best-characterized downstream targets of
mTORC1 involved in mRNA translation include the ribosomal
protein S6 (rpS6) kinases (S6Ks) (11), eukaryotic initiation factor-
4E-binding proteins (4E-BPs) (12), and eukaryotic elongation
factor 2 (eEF2) kinase (eEF2K) (13–16).
eEF2K is a Ca2/calmodulin (CaM)-dependent protein kinase
that phosphorylates eEF2 on Thr56 and impairs the binding of
eEF2 to ribosomes, thereby inhibiting elongation (17, 18). eEF2K
is activated by low pH in vitro (19). However, the mechanism
underlying this effect and its physiological and pathological sig-
nificance remained obscure. Here, we show that eEF2K is acutely
activated in cells during acidosis. Furthermore, we identify the
specific histidine residues in eEF2K, and in CaM, that are involved
in the activation of eEF2K at low pH. Finally, we show that eEF2K
confers cellular resistance to acidosis, promoting cancer cell sur-
vival. These results provide a rationale for using eEF2K inhibitors
as anticancer drugs against tumor cells in acidic environments.
MATERIALS AND METHODS
Chemicals and reagents. All chemicals were from Sigma-Aldrich unless
otherwise stated. The Bradford assay reagent was from Bio-Rad. [-
32P]ATP and [35S]methionine-cysteinewere fromPerkinElmer. Rapamy-
cin was from Merck. AZD8055 was kindly provided by AstraZeneca.
Isopropyl--D-1-thiogalactopyranoside (IPTG) was from Promega.
A484954 was from Tocris Bioscience. Peptides were made by China Pep-
tides (Shanghai, China).
Cell lines.Mouse embryonic fibroblasts (MEFs) from eEF2K/mice
and matched wild-type (WT) counterparts were prepared from embryos
at day 13.5. AMPK1/2/ and AMPK1/2/ MEFs are kind gifts
from Benoît Viollet (Institut Cochin, University of Paris). TSC2/ and
TSC2/MEFs were kindly provided by David J. Kwiatkowski (Harvard
Medical School, Boston, MA). 4EBP1/2/ and 4EBP1/2/MEFs were
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kindly provided by Nahum Sonenberg (McGill University, Montréal,
Canada). HCT116 and A549 cells expressing inducible short hairpin RNA
(shRNA) against eEF2Kwere generously provided by JanssenPharmaceu-
tica. To induce knockdown of eEF2K, cells were cultured for 5 days with 1
mM IPTG prior to use.
Animals.Mice weremaintained at Biomedical Research Facility, Uni-
versity of Southampton, in line with the United Kingdom Animals (Sci-
entific Procedures) Act 1986.
Cell culture and lysis. HEK293 cells, MEFs, and A549 cells were cul-
tured in Dulbecco’s modified Eagle medium (DMEM); HCT116 cells
were maintained in McCoy’s 5A medium containing 10% (vol/vol) fetal
bovine serum and 1% penicillin-streptomycin. pH was adjusted by add-
ing different concentrations of NaHCO3.
After treatment, cells were lysed by scraping into ice-cold lysis buffer
containing 1% (vol/vol) Triton X-100, 20 mM Tris-HCl (pH 7.5), 150
mMNaCl, 1mMEDTA, 1mMEGTA, 2.5mMNaH2P2O7, 1mM-glyc-
erophosphate, 1 mM Na3VO4, and protease inhibitor cocktail (1). Ly-
sates were spun at 16,000 g for 10 min, the supernatants were kept, and
total protein concentration was quantified by the Bradford assay.
Generation of eEF2K knockout MEFs. The generation of eEF2K
knockout mice was as described in reference 20. MEFs from these mice
andmatched wild-type counterparts were prepared from embryos at em-
bryonic day 13.5.
Real-time RT-PCR amplification analysis. Total RNA was extracted
using TRIzol (Life Technologies). cDNA was produced using the Im-
Prom-II reverse transcription (RT) system (Promega) with oligo(dT)15.
Subsequently, real-time PCR was performed using specific primers
(PrimerDesign) for human eEF2K (5=-CCAGCCAAGACTTCAGTGTT-
3=; 5=-ATTTTACCTGCTTCATTGTTCATTTAA) and 18S rRNA (HK-
SY-hu-600 from PrimerDesign) as a control. Samples were analyzed in
triplicate (for each experiment) with SYBR green dyemix (PrimerDesign)
on an ABI Step One Plus qPCR (quantitative PCR) instrument (Applied
Biosystems). The comparative threshold cycle (CT) method was used to
determine the amount of specific mRNAs compared with the level of 18S
rRNA.
Plasmid transfections. mCherry/de4GFP fusion plasmid was a kind
gift from Michel Roberge (University of British Columbia, Vancouver,
Canada [21]). pHM-FLAG-eEF2K wild-type and K170M vectors were
described previously (22). pcDNA3.1-FLAG-Rheb was from Addgene
(plasmid 19996; Cambridge,MA).Greenfluorescent protein (GFP)-spec-
trinwas a kind gift fromTerence P.Herbert (RoyalMelbourne Institute of
Technology, Melbourne, Australia). HEK293 cells were transfected using
the calcium phosphate method (23). Plasmid transfections in HCT116
cells were performed using FuGENE HD (Promega).
Intracellular pH measurement. Intracellular pH measurement was
performed as described in reference 21. Briefly, fluorescent signals of the
pH-sensitive de4GFP (excitation, 488 nm) and the pH-insensitive
mCherry (excitation, 543 nm) were captured by a Leica Confocal micro-
scope. A standard curve was established using the high-[K]/nigericin
technique, and changes in intracellular pH in response to extracellular pH
were determined by measuring the mCherry/de4GFP fluorescence ratios,
which were then converted to pH via interpolation on the calibration
curve.
SDS-PAGE andWestern blot analysis. SDS-PAGE andWestern blot
analysis were performed as previously described (24). Anti-P-eEF2 Thr56
and eEF2K were from Eurogentec, and anti-S6K1, rpS6, FLAG, TSC2,
tubulin, and NHE-1 were from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti-P-eEF2K Ser441/Ser445was a gift fromDanieleGuardavaccaro
(Hubrecht Institute-KNAW and University Medical Centre Utrecht,
Netherlands). All other antibodies were purchased from New England
BioLabs (Hitchin, Herts, United Kingdom).
mTOR complex immunoprecipitation and mTORC1 kinase assay.
mTOR complexes were immunoprecipitated as previously described
(25). For mTORC1 kinase assays, after washing with lysis buffer, mTOR
complex immunoprecipitates were further washed twice in reaction buf-
fer (25 mM HEPES at pH 6.0, 6.6, or 7.4, 50 mM NaCl, 20% glycerol, 10
mM MgCl2, 4 mM MnCl2, and 1 mM dithiothreitol [DTT]), and assays
were performed in 20 l reaction buffer containing 1 g recombinant
4E-BP1, 50mMunlabeledATP, and 1Ci [-32P]ATP at 30°C for 20min.
Reactions were stopped by adding 20 l of 2 Laemmli sample buffer;
samples were then heated at 100°C for 4 min followed by SDS-PAGE.
Proteins were stained with Coomassie blue, and phosphorylated 4E-BP1
was detected by a Typhoon FLA 7000 phosphorimager (GE Healthcare).
Protein expression, mutagenesis, and purification. The expression
vector pNIC28-Bsa4 containing the sequence for wild-type CaMwas gen-
erously provided by the SGC (Oxford). Point mutations were introduced
byPCRmutagenesis using theQuikChange system (Stratagene). CaMwas
expressed in Escherichia coli BL21(DE3) cells. Protein purifications were
performed as described previously (26).
eEF2K assays. To assay endogenous eEF2K, protein G beads were
preincubated with eEF2K antibody at 4°C overnight. After treatment and
lysis, 100 g HEK293 cell lysate was incubated with protein G beads plus
FIG 1 Extracellular acidosis inhibits mTORC1 and activates eEF2K. (A) HEK293 cells were incubated in pH-buffered medium or normal culture medium for
30 min with/without 100 nM rapamycin (Rap). (B and C) HEK293 cells were incubated in pHmedia buffered to different pHs for the indicated periods of time
or in culture medium in the presence or absence of 0.5 mMNaAsO2 for 2 h. The levels of total and phospho-eIF2 (Ser51) were analyzed by Western blotting.
(D) HEK293 cells transfected with mCherry/de4GFP were under high-[K]/nigericin pH clamp from pH 6.0 to 8.0 for 10 min. An increase in red fluorescence
indicates an acidic pH shift. The standard curve was established by determining the relationship between pH and the green/red fluorescence ratio. (E) HEK293
cells transfected with mCherry/de4GFP were cultured in either pH-buffered or culture medium (CM) for the indicated times. The intracellular pH of cells was
determined via interpolation of green/red fluorescence ratio into the standard curve illustrated in panel D. (F) HEK293 cells were incubated inmedium buffered
at pH 6.6 or 7.4 for the indicated times. (G) HEK293 cells were cultured at pH 6.6 or 7.4 buffered medium for up to 7 h, and expression of EEF2K mRNA was
quantified by real-time RT-PCR. Results are given asmeans	 standard errors (SE) from 3 independent experiments and expressed as a percentage of the control
(pH 7.4). *, 0.01 P
 0.05 as determined by two-way analysis of variance (ANOVA). (H) HEK293 cells were transfected with vectors for wild-type or K170M
(kinase-dead) FLAG-tagged eEF2K; 24 h later, cells were cultured at pH 6.6 or 7.4 for 7 h before lysis. (I) HEK293 cells were cultured at pH 6.0 or 7.4 buffered
medium for 30 min, eEF2K was immunoprecipitated from the lysates, and Ser359 phosphorylation was analyzed by Western blotting. For all SDS-PAGE and
Western blot experiments, data shown are representative of three independent experiments.
FIG 2 eEF2K is responsible for the induction of eEF2 phosphorylation under
acidosis. eEF2K/ or eEF2K/MEFs were cultured at pH 6.0, 6.6, or 7.4 for
24 h. Blots were developed with the indicated antibodies. Data shown are
representative of three independent experiments.
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eEF2K antibody for 2 h at 4°C. eEF2K activity assays were performed as
described in reference 26 using recombinant eEF2Kprepared inE. coli; the
CaM concentration was 16 ng/assay volume (unless otherwise stated).
ELISA for CaM binding. Wells of a Maxisorp enzyme-linked immu-
nosorbent assay (ELISA) tray (Nunc) were coated overnight at 4°C with
0.2 g/ml CaM in phosphate-buffered saline (PBS). Wells were then
washed with PBST (PBS plus 0.05% Tween 20) and blocked with 5%
bovine serum albumin (BSA) in PBST. eEF2K peptides corresponding to
residues 76 to 95 [eEF2K(76–95)] (wild-type andmutant) were diluted in
buffer containing 50 mMMOPS (morpholinepropanesulfonic acid), 100
mMNaCl, 2 mMCaCl2, 0.05% Tween 20, and 0.5% BSA, adjusted to the
desired pH. One hundred microliters of the peptides was added to the
wells and incubated for 1 h at room temperature. Wells were washed with
buffer containing 50mMMOPS, 100mMNaCl, 2 mMCaCl2, and 0.05%
Tween 20 adjusted to the corresponding pH. Bound glutathione S-trans-
ferase (GST)–eEF2K was detected using an anti-GST antibody followed
by anti-IgG–horseradish peroxidase (HRP) antibody.
ITC. Isothermal titration calorimetry (ITC) measurements were car-
ried out using an iTC200MicroCalorimeter (GEHealthcare) at 25°C. CaM
and all peptideswere prepared anddialyzed in the samebuffer, i.e., 20mM
piperazine-N,N=-bis(2-ethanesulfonic acid) (PIPES), 150 mMNaCl, and
10mMCaCl2, pH 6.8 or pH7.5). Ligandwas titrated into protein solution
corresponding to approximately 230 M ligand (peptide) and 18 M
protein (CaM). Each experiment consisted of an initial injection of 0.3l
followed by 39 injections of 1 l peptide solution into the cell containing
CaM, while stirring at 800 rpm. Control titrations (peptide into buffer)
were measured. Data acquisition and analysis were performed using the
Origin scientific graphing and analysis software package (OriginLab).
Data analysis was performed by generating a binding isotherm and best fit
using the following parameters:N (number of sites), H (calories/mole),
S (calories/mole/degree), andK (binding constant in molar1). Follow-
ing data analysis, K was converted to the dissociation constant (Kd) (mi-
cromolar).
CaMK1 assays. GST-CaMK1 and CaMK1 substrate (EP2544 [YLRR
RLSDSNF]) were purchased from the University of Dundee, Division of
Signal Transduction Therapy, and diluted in 50 mM Tris-HCl (pH 7.5),
10 mM DTT, 1 mg/ml BSA. CaMK1 assays were carried out at 30°C by
incubating 0.9 g CaMK1 in 40 l of 50 mM Tris-HCl (pH 7.5), 10 mM
FIG 3 mTORC1 inhibition is not responsible for the activation of eEF2K under acidosis. (A) AMPK/ or AMPK/ MEFs were incubated in pH-buffered
medium for 30min. *, nonspecific band. (B) TSC2/ and TSC2/MEFswere cultured in pHbufferedmedium for 1 hwith/without 100 nMAZD8055 (AZD).
(C) HEK293 cells transfected with either an empty vector or one encoding FLAG-tagged Rheb were cultured at different pHs for 30 min. Blots were developed
with the indicated antibodies. (D) HEK293 cells were incubated in pH buffered media for 30 min, and cells were lysed in lysis buffer containing 3-[(3-
cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS). Samples of lysate were analyzed by immunoblotting for the indicated proteins. mTOR
complexes were isolated via immunoprecipitation, and the integrity of mTORC1 was then analyzed by Western blotting for components of this complex. For
panels A and D, data shown are representative of three independent experiments, For panels B and C, data shown are representative of five independent
experiments.
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DTT, 10 mMmagnesium acetate, 0.1 mM CaCl2, 1 MCaM (19.4 ng/l
or as indicated in the figure legends), 300 M EP2544, and 1 Ci [-
32P]ATP. Samples were taken at 5, 10, 15, and 30 min by spotting 8-l
aliquots from the 40-l assay mixture onto squares of Whatman P81
paper (2 cm by 2 cm), which were washed three times (5 min each) in 75
mM phosphoric acid followed by methanol before drying in air and scin-
tillation counting.
IHC. An appropriately consented archival lung adenocarcinoma was
selected for optimization and demonstration of markers by immunohis-
tochemistry (IHC). Sequential 4-m sections were stained by IHC using
the EnvisionFLEX visualization system (Dako) and Autostainer Link48
automated platforms (Dako). Primary antibodies GLUT-1, NHE-1, and
P-eEF2 Thr56 were retrieved, visualized, and counterstained with hema-
toxylin. Images were taken using a Zeiss Axio Scope A1microscope (mag-
nification,200) and an Axiocam MRc5 camera (5 megapixel).
NMR studies. All nuclear magnetic resonance (NMR) experiments
were recorded at 600 MHz at 298 K on a Varian INOVA-600 instrument
fitted with a z-gradient cold probe (Agilent technologies). One-dimen-
sional (1D) proton spectra were recorded with an acquisition time of 0.4 s
using 1D sequence with Watergate water suppression as implemented in
Biopack (Agilent Technologies). The 1H resonances were referenced to
(3-trimethyl silyl)propionate-2,2,3,3-d4 (sodium salt) at 0 ppm and pro-
cessed with mild resolution enhancement and water deconvolution in
VnmrJ3.1 (Agilent Technologies).
Peptide samples corresponding to residues 78 to 100 of eEF2K [re-
ferred to here as eEF2K(78–100)]were prepared inD2Obuffer containing
FIG 4 Effects of pH on mTORC1 and eEF2K kinase activity. (A) HEK293 cells were incubated at different pHs for 30 min, and mTOR complexes were
immunoprecipitated and subjected tomTORC1 activity assay with [-32P]ATP. (B) ThemTORC1 activity assay was performed as described for panel A but with
nonradiolabeled ATP. (C) eEF2Kwas immunoprecipitated from lysates of HEK293 cells cultured at pH 7.4 for 30min, followed by assays for the indicated times.
(D)HEK293 cells were cultured at pH 6.6, 7.0, or 7.4 for 30min, and eEF2Kwas immunoprecipitated from cell lysates and subjected to activity assays for 10min.
(E) As described for panel D, except that the activity assays were performed for 30min using nonradiolabeledATP. For panels A, B, andD, upper panels represent
the samples of the lysates (inputs) that were subsequently used in kinases assays. Data shown are representative of three independent experiments.
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25 mM bis-Tris, 150 mMKCl, and 10 mMCaCl2. Twenty-eight 1D spec-
tra were recorded over a pH range of 4.8 to 8.9. The chemical shifts of the
CH2 protons of the imidazole side chains of the histidine residues were
determined with an accuracy of 0.02 ppm. The data were fitted to the Hill
equation (27) using a Hill coefficient of 1 and allowing the pKa to vary
using nonlinear fitting routines inGrace (GraceDevelopment Team). The
pKa of the imidazole ring of histidine was determined to be 6.13 in a
separate titration. pKa values were corrected by 0.04 units to account for
the isotope effect of D2O (28).
UV cross-linking/ATP binding assay. The binding of eEF2K to ATP
was studied by UV cross-linking as described in reference 26. Briefly,
recombinant GST-eEF2K was incubated in the presence or absence of
CaM (16 ng/assay) and [-32P]ATP. UV irradiation was performed using
a hand-held light source (UVP model UVGL-58 Mineralight lamp with
emission wavelengthmaximum at 254 nm) held 2 to 3 cm above the open
microcentrifuge tube containing the sample for 60 min. Samples were
then subjected to SDS/PAGE and autoradiography.
Cell ATP/viability assay.Cells were cultured in 96-well plates for 48 h;
ATP levels weremeasured using the CellTiter-Glo luminescent cell viabil-
ity assay kit (catalog number G7570; Promega).
Cell death/cytotoxicity assay.Cells were cultured in 96-well plates for
48 h unless otherwise specified. Cytotoxicity was determined using the
CellTox Green assay (catalog number G8741; Promega), which measures
changes in cell membrane integrity.
Flow cytometry analysis. Following treatment, the cells were
trypsinized and fixed in 90%methanol. Cells were pelleted by centrifuga-
tion at 200  g for 5 min and resuspended in 1 ml PBS containing 20
g/ml propidium iodide and 100 g/ml RNase A. Quantification of pro-
pidium iodide staining was performed using a FACSCalibur flow cytom-
eter (BD Biosciences). A total of 20,000 gated events were recorded per
sample.
Protein synthesis measurements. Cells were preincubated in pH-
buffered methionine-, cysteine-, and NaHCO3-free DMEM (customized
by Labtech International, United Kingdom) for 1 h, before the addition of
10 Ci [35S]methionine-cysteine and incubation for a further hour. In-
corporated radioactivity was determined as described previously (24).
Polysome analysis. Polysome analysis was performed as described
previously (24).
RESULTS
Activation of eEF2K and suppression of mTORC1 activity un-
der extracellular acidosis. Previous data showed that eEF2 phos-
phorylation increases when mouse liver extract is incubated in
acidifiedHEPES-KOHbuffer and that the activity of recombinant
eEF2K kinase is enhanced by acidic pH in vitro (19). However, it
was unknown if acidic cytosolic pH increases endogenous eEF2K
activity in cells directly or indirectly, via upstream signaling
events, e.g., extracellular acidosis can inhibit mTORC1 signaling,
and this is mainly TSC2 dependent (5, 29). To study this, we cul-
tured HEK293 cells in acid-buffered growth medium for 30 min.
As expected, extracellular acidosis increased eEF2 phosphoryla-
tion, indicating activation of eEF2K, and decreased mTORC1 sig-
naling, as shown by the diminished phosphorylation of S6K1 and
S6 and the increased mobility of S6K1 and 4EBP1 on SDS-PAGE
(Fig. 1A). In contrast, acidic pH did not affect eIF2 phosphory-
lation, which often increases in response to stresses (e.g., sodium
arsenite) (Fig. 1B and C). In addition, extracellular acidification
decreases intracellular pH (Fig. 1D and E).
To study the effect of acidosis onmTORC1/eEF2K-related sig-
naling over longer times,HEK293 cells were incubated inmedium
buffered at pH 6.6 or pH 7.4 for up to 7 h (Fig. 1F). Interestingly,
we observed a decrease in both eEF2KmRNA (after 5 h [Fig. 1H])
and eEF2K protein levels (after 3 h [Fig. 1G]) at pH 6.6. However,
despite the decreased eEF2K levels, eEF2 phosphorylation re-
mained higher at pH 6.6 than at pH 7.4 for up to 7 h, indicating
sustained activation of eEF2K. The activity of eEF2K is clearly
required for its degradation, since kinase-dead eEF2K (K170M)
was stable at pH 6.6 (Fig. 1H).
We have recently generated eEF2K/ (knockout) mice (20).
MEFs from these mice and matched wild-type counterparts were
prepared from embryos at embryonic day 13.5. We confirmed
that the phosphorylation of eEF2 during acidosis was exclusively
mediated through eEF2K, because it was absent in eEF2K/
MEFs (Fig. 2).
We also observed a time-dependent impairment of mTORC1
signaling in HEK293 cells cultured at pH 6.6, whereas mTORC2
activity, assessed by phosphorylation of PKB at Ser473 (30), was
unaffected (Fig. 1F). Phosphorylation of PKB at Thr308, essential
for its stimulation (31), was also unaffected (Fig. 1F). Changes in
ERK phosphorylation did not correlate with changes in eEF2K
activity or mTORC1 signaling (Fig. 1F). SAPK4, whose activity
has been shown to be inhibited under acidic conditions (32), is
able to phosphorylate eEF2K at Ser359, which strongly inhibits its
activity (13), so that an increase in SAPK4 activity could not acti-
vate eEF2K in this way. Nevertheless, we have tested whether low
pHaffects phosphorylation of eEF2K at Ser359. It did not, while in
contrast, the mTOR inhibitor AZD8055 did, as expected, block
phosphorylation of eEF2K at Ser359 (Fig. 1L). Although low pH
does impair mTORC1 activity (Fig. 3), it does not affect Ser359
phosphorylation. The reason for this is currently unknown. Nev-
ertheless, this is good evidence that SAPK4 does not play a role in
that acidosis-induced activation of eEF2K.
Interestingly, acidosis also decreased phosphorylation (activa-
tion) of AMPK and ACC (a substrate for AMPK) (Fig. 1F). In
AMPK/MEFs, eEF2 and S6K1 phosphorylation levels were still
altered by acidosis, similar to what was seen in wild-type MEFs
(Fig. 3A). Thus, AMPK is not required for acidosis-induced
changes in eEF2K and mTORC1 signaling. Notably, eEF2K ex-
pression is lower in AMPK/ cells than in WT cells, suggesting
that AMPK regulates eEF2K expression.
mTORC1 negatively regulates eEF2K activity (13–16); thus,
inhibition of mTORC1 by acidosis might increase eEF2K activity.
However, although rapamycin effectively did slightly increase
eEF2 phosphorylation in HEK293 cells, eEF2 phosphorylation
was much higher in cells cultured under acidic conditions than in
rapamycin-treated ones, suggesting that acidosis-induced eEF2K
activation is independent of inhibition ofmTORC1 signaling (Fig.
1A). Furthermore, in TSC2/ MEFs, where mTORC1 is hyper-
FIG 5 Histidine residues within the CaM-binding site of eEF2K are important for eEF2K activation under low pH. (A) eEF2K activity assay with or without
wild-type recombinant eEF2K at either pH 6.9 or 7.4. (B) eEF2K activity assays with the indicated amount of CaM per assay. (C) Sequence alignment of eEF2K
CaM-binding domain among species. (D) Chemical shift titration curves for the CH2 protons of the imidazole side chains of the 3 histidine residues in
eEF2K(82–100). (E)Activity ofWTeEF2K compared to the single or doubleH80A/H87A/H94Amutants. (F)Comparison of the activity ofwild-type eEF2Kwith
that of theH80A/H87A/H94A triplemutant. (G) eEF2K assay for eEF2K(H80K/H87K/H94K). Results aremeans	 SE, n 3.P values were obtained by two-way
ANOVA followed by Dunnett’s test. *, 0.01 P
 0.05; #, 0.01
 P 0.001; $, P
 0.001.
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activated, eEF2 still became phosphorylated under acidic condi-
tions, although eEF2 phosphorylation was lower in TSC2/
MEFs than in wild-type cells, perhaps reflecting lower levels of
eEF2K protein (Fig. 3B). Inhibiting mTORC1 using the ATP-
competitive mTOR inhibitor AZD8055 (33) restored eEF2K pro-
tein levels in TSC2-null MEFs, suggesting that mTORC1 hyperac-
tivation negatively regulates eEF2K expression (Fig. 3B).
Furthermore, in HEK293 cells exogenously expressing Rheb,
which causes constitutive activation ofmTORC1, eEF2 phosphor-
ylation remained sensitive to changes in extracellular pH, al-
though eEF2 phosphorylation was lower in Rheb-transfected cells
than controls (Fig. 3C). At pH 7.4, Rheb overexpression led to a
decrease in eEF2K expression. mTORC1 activation was inhibited
when pH was decreased, which might be responsible for rescuing
the expression of eEF2K (Fig. 3C). The data suggest that although
acidosis-induced eEF2K stimulation is unlikely to be mediated by
inhibition of mTORC1, hyperactive mTORC1 signaling in TSC-
null cells may partially suppress eEF2 phosphorylation at low pH,
by impairing the expression and activity of eEF2K.
Acidosis directly inhibits mTORC1 kinase activity and pro-
motes the activation of eEF2K. Although mTORC1 activity was
less sensitive to changes in ambient pH in TSC2/MEFs than in
WTMEFs, acidification still inhibitedmTORC1 in them (Fig. 3B),
suggesting that pH might directly affect mTORC1’s catalytic ac-
tivity. To study this, HEK293 cells were incubated in medium
buffered at physiological (7.4) or acidic (6.6 or 6.0) pH, with or
without AZD8055. After lysis, mTOR complexes were immuno-
precipitated from cell lysates and assayed in vitro at pH 7.4 or 6.6
against recombinant 4E-BP1. The activity of mTORC1 isolated
from cells preincubated in acidic pH-buffered medium was lower
than that of mTORC1 from control cells (Fig. 4A and B). Impor-
tantly, decreased activity was also seen when mTORC1 from con-
trol cells was assayed at pH 6.6. mTORC1 is comprised of several
proteins, including in particular RAPTOR (essential for
mTORC1), mLST8, and PRAS40 (34). Low pH (6.6 and 6.0) does
not affect the binding of these proteins to mTORC1 (Fig. 3D).
Therefore, mTORC1 kinase activity is substantially decreased at
acidic pH values such as those encountered during acidosis (i) by
stable changes that occur within the cell and (ii) because mTOR is
itself less active at lower pH.
The activity of recombinant eEF2K is enhanced under acidic
conditions in vitro (19), but it remained unclear whether this also
applied to endogenous eEF2K. Endogenous eEF2K was immuno-
precipitated from lysates of HEK293 cells that had been preincu-
bated in bufferedmedium (pH 7.4, 7.0, or 6.6), and its activity was
assayed using purified eEF2. eEF2 was more rapidly phosphory-
latedwhen the assaywas performed at pH6.9 than 7.4, confirming
that acidic pH increases eEF2K activity (Fig. 4C to E). As expected,
endogenous eEF2K purified from cells kept at pH 7.4 and treated
with AZD8055 also showed increased catalytic activity (Fig. 4D
and E), and this was further enhanced when assayed at pH 6.9,
providing additional evidence that activation of eEF2K under ac-
idosis is independent of mTORC1 inhibition. Thus, endogenous
eEF2K is indeed directly activated by low pH in cells, resulting
from stablemodification(s) of eEF2K and/or an effect of pH on its
intrinsic activity.
Protonation of histidines in the CaM-binding domain of
eEF2K is involved in the increase in eEF2K activity at acidic pH.
It was important to elucidate the molecular mechanism through
which pHaffects eEF2K activity.Wefirst performed in vitro kinase
assays using recombinant eEF2K. To ensure accurate, easily quan-
tifiable data, we used the MH-1 peptide as the substrate (35).
Reactions were within the linear range (Fig. 5A). eEF2K activity
was higher when assayed at acidic pH (6.9) than at pH 7.4 (Fig.
5A), and eEF2K activity was dependent upon CaM (Fig. 5B).
Earlier data indicated that acidic conditions promote binding
of eEF2K to CaM, thereby enhancing eEF2K activity (19, 26). The
imidazole group of histidine ionizes around neutral pH. The
CaM-binding region of eEF2K contains three highly conserved
histidines (H80, H87, and H94) (Fig. 5C). To study their proper-
ties in detail, without interference from other histidines in eEF2K,
we synthesized a peptide corresponding to residues 78 to 100 of
eEF2K. NMR studies showed that the pKa values of these histi-
dines are pH 6.45, 6.5, and 6.6, i.e., in the range where eEF2K
activity is sensitive to pH (Fig. 5D). (Note that we cannot identify
which histidine corresponds to which pKa from these data.) This
prompted us to test their importance for the effect of pH on bind-
ing of CaM to eEF2K. When 1 or 2 of these histidines were re-
placed by nonionizable alanines, eEF2K activity was still enhanced
at lower pH. Indeed, eEF2K(H87A) and eEF2K(H94A) actually
displayed enhanced kinase activity at pH 6.9 (Fig. 5E). However,
when all three histidines were mutated to alanine (H80A/H87A/
H94A [H3A]), the activation of eEF2K at acidic pH was greatly
blunted (Fig. 5F). Conversely, when all three were mutated to
lysines (H80K/H87K/H94K [H3K]), which are charged at both
acidic pH and physiological pH, eEF2K activity was enhanced at
both pH values (Fig. 5G). Consistent with this, the affinity of the
peptide eEF2K(78–100)(H3A) for CaM was decreased (Kd 
97	 9 nM) compared to that of the corresponding peptide based
onWTeEF2Kunder acidic conditions (Kd 38	 3 nM),whereas
CaM binding to eEF2K(78–100)(H3K) peptide was tighter (Kd
32.5 	 3.2 nM) than the WT peptide (Kd  66 	 9.3 nM) at
physiological pH (Fig. 6A, B; Table 1). eEF2K(78–100)(W85G), a
mutant that is unable to bind CaM (26), was used as a negative
control. These data strongly suggest that protonation of all 3 his-
tidines promotes binding of CaM to eEF2K, contributing to the
stimulation of eEF2K activity at acidic pH.
However, although the activity of eEF2K(H3K) was higher at
pH 7.4, it still increased 1.9-fold at lower pH, although less so than
forWT eEF2K (3.8-fold [Fig. 5G]), implying that additional (per-
haps histidine) residues in eEF2K play roles in its acidosis-medi-
ated activation. There are two highly conserved histidine residues
(H227 and H230) in the ATP-binding site of eEF2K (Fig. 7A and
B). eEF2K(H227K) was inactive at pH 7.4 or 6.9. At physiological
FIG6 eEF2KH80/H87/H94 are important for CaMbinding to eEF2Kunder low pH. (A)CaMELISA using the eEF2K(76-95) peptide based onwild-type eEF2K
or H80A/H87A/H94A (H3A), H80K/H87K/H94K (H3K), and W85G mutant peptides. Results are expressed as means	 SE from 3 independent experiments.
P values were obtained by two-way ANOVA followed by Dunnett’s test. *, 0.01  P 
 0.05; #, 0.01 
 P  0.001; $, P 
 0.001. (B) Calorimetric titrations of
wild-type CaMwith the eEF2K peptides (78–100) (WT, H80A/H87A/H94A [H3A], and H80K/H87K/H94K [H3K]) at pH 6.8 and 7.5. These experiments were
performed at 25°C in 20 mM piperazine-N,N=-bis(2-ethanesulfonic acid) (PIPES) 150 mM KCl, and 10 mM CaCl2 at either pH 6.8 or pH 7.5 as described in
Materials andMethods. In all cases, the upper graph represents the original titration curve while the lower graph shows the binding isotherm obtained from the
experiments shown in the top graph (these data are related to those given in Table 1).
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pH, eEF2K(H227A), eEF2K(H230A), and eEF2K(H230K) all
showed activities similar to those of wild-type eEF2K. At acidic
pH, the activity of eEF2K(H230K) was lower than that of wild-
type eEF2K (Fig. 7C). Interestingly, eEF2K(H227A/H230A)
showed activity similar to that of wild-type kinase at pH 7.4,
whereas its activity was not enhanced at acidic pH (Fig. 7D). Consis-
tent with these data, eEF2K(H227K) and eEF2K(H227KH230K)
were unable to bind ATP as judged from UV cross-linking using
[-32P]ATP (Fig. 7E). eEF2K(D274A), an inactive mutant (35),
was also unable to bind ATP and was used as a control.
eEF2K(H227A/H230A) strongly bound to ATP (Fig. 7E) but still
showed reduced activity at pH 6.9 compared to the wild-type
eEF2K (Fig. 7D). Therefore, protonation of these two histidines
appears likely to be required for the activation of eEF2K at acidic
pH, not simply for binding ATP.
H108 in CaM contributes to activation of eEF2K at low pH.
The sole, highly conserved histidine residue in CaM (H108; Fig.
8A, B) could also be involved in the effect of acidification onCaM-
eEF2K binding. Interaction sites on CaM for eEF2K have been
identified by NMR chemical shift perturbation analysis (K. J.
Hooper, H. Mikolajek, and J. M. Werner, unpublished data), but
H108 is outside this region and therefore unlikely to be involved in
binding eEF2K. However, the CaM(H108K) mutant failed to ac-
tivate eEF2K (Fig. 8C). Nevertheless, both CaM(H108A) and
(H108K) still bound eEF2K(78–100) [at pH 6.8,KdCaM(H108A)
 42 nM;KdCaM(H108K) 122 nM] (Fig. 8D), although, in the
case of CaM(H108K), not as well as wild-type CaM (Kd 38 nM
at pH 6.8 [Fig. 6B]). The impaired ability of CaM(H108A) to
activate eEF2K cannot reflect an effect on eEF2K binding. Impor-
tant to note is that the CaM concentration used in previous assays
does not reach saturation, so that for the H108K mutant, its in-
ability to activate eEF2K may reflect, but probably partly, de-
creased affinity for eEF2K (Fig. 5B). These data strongly suggest
that H108 in CaM is required for the ability of CaM to activate
eEF2K independently of the modest alteration in binding affinity.
To assess whether H108 played a general role in the activation of
kinases by CaM, we also studied its role in activating another
CaM-dependent kinase, CaMK1. CaMK1 was activated to similar
extents by wild-type CaM, H108A, or H108K, at either pH 7.4 or
6.8 (Fig. 8E andF). Thus,H108 inCaMdoes not play a general role
in activating CaM-dependent kinases.
eEF2K promotes cancer cell survival under acidosis. While
the environment around normal tissues is pH 7.2 to 7.4, the ex-
tracellular pH around malignant tumors is usually between 6.5
and 6.9 (36) and may fall to 6.2 (37). Acidic extracellular pH is
toxic to normal cells, yet cancer cells can withstand acidic envi-
ronments (3). Notably, in human lung adenocarcinoma tissues,
high expression levels ofNHE-1 andGLUT-1 (glucose transporter
1), markers of tumor acidification (7), coincided with high levels
of eEF2 phosphorylation (Fig. 9A and B). eEF2K has recently been
shown to be critical for cancer cell survival during nutrient depri-
vation, another condition underwhich eEF2K is activated (38); we
therefore asked whether eEF2K also helps cancer cells resist acido-
sis-induced cell death. To test this, two cancer cell lines, A549
(human lung adenocarcinoma) and HCT116 (human colon car-
cinoma) cells expressing an inducible shRNA against eEF2K were
developed. Cells were also treated with etoposide, a cytotoxic to-
poisomerase inhibitor, as a positive control. eEF2 phosphoryla-
tion increased when control A549 or HCT116 cells were cultured
at low pH (6.4 and 6.8), although eEF2 phosphorylation dropped
by 48 h (Fig. 9C and D). Total eEF2K levels in acidic pH-buffered
medium cultures fell in A549 cells and more slowly in HCT116
cells (Fig. 9C andD). The fact that eEF2 phosphorylation increases
even though eEF2K levels actually decline at lower pH strongly
supports the notion that the intrinsic activity of eEF2K is strongly
enhanced at low pH.
Induction of shRNA against eEF2K effectively knocked down
eEF2K expression and decreased eEF2 phosphorylation under
acidic conditions in A549 cells (Fig. 9E). eEF2K knockdown was
less effective in HCT116 cells (we still observed residual eEF2
phosphorylation at low pH [Fig. 9F]). Extracellular acidification
decreased cellular ATP levels, and this was enhanced upon
shRNA-mediated eEF2K knockdown in A549 or HCT116 cells
(Fig. 10A and B). This likely reflects the fact that eEF2K negatively
regulates translation elongation (17, 18), a process in which al-
most all the energy needed by protein synthesis is consumed.
eEF2Kmay be cytoprotective under acidosis (as it is during nutri-
ent starvation [38]). We did indeed observe increased cell death
under low pH, as revealed by the CellTox green cytotoxicity assay,
and a higher sub-G1 population, and this was further increased
upon eEF2K knockdown in A549 (Fig. 10C and D) or HCT116
(Fig. 10E and F) cells.
Depletion of eEF2K by shRNA in A549 cells led to a small
decrease in S6K1 phosphorylation at pH 7.4 but did not affect
mTORC1 signaling under other pH conditions (Fig. 9G), indicat-
ing that loss of eEF2K activity, rather than an effect on mTORC1,
accounts for acidosis-mediated cell death. In contrast, acidosis did
not increase cell death in eEF2K/ or eEF2K/MEFs (J. Xie and
C. G. Proud, unpublished results) and we cannot use them to
assess whether eEF2K plays a cytoprotective role.
While these data demonstrate that eEF2K plays an important
role in maintaining cancer cell survival under acute extracellular
acidosis, solid tumors can be surrounded by an acidic microenvi-
ronment for months in vivo. To test whether eEF2K plays roles in
TABLE 1 Isothermal titration calorimetric analysis of the binding of calmodulin to peptides corresponding to residues 78 to 100 of eEF2Ka
Peptide pH Kd (nM) H (kcal/mol) S at 298K (cal/mol) TS (kcal/mol) G (kcal/mol) N
Wild type 6.8 38 (	2.6) 16.8 (	0.53) 22.6 6.7 10.1 1.02 (	0.03)
Wild type 7.5 66 (	9.3) 15.2 (	0.7) 18.4 5.4 9.7 0.98 (	0.03)
H3A 6.8 97 (	6.5) 11.2 (	0.5) 5.6 1.6 9.5 1.03 (	0.09)
H3A 7.5 99 (	1.7) 11.9 (	0.4) 7.9 2.3 9.5 0.953 (	0.009)
H3K 6.8 28 (	4.1) 13.2 (	0.4) 9.7 2.9 10.3 0.97 (	0.005)
H3K 7.5 32.5 (	3.2) 13.3 (	0.3) 10.4 3.1 10.2 0.946 (	0.01)
a Errors (in parentheses) are expressed as standard errors of the means for three independent experiments. Thermodynamic parameters were obtained by fitting the ITC data to a
single-state binding model. H3A, H80A/H87A/H94A; H3K, H80K/H87K/H94K; N, stoichiometry of the interaction determined in the experiment; Kd, dissociation constant (Kd is
the reciprocal of Ka); H, change in enthalpy; S, change in entropy; G (Gibb’s free energy), H TS.
Xie et al.
1814 mcb.asm.org May 2015 Volume 35 Number 10Molecular and Cellular Biology
 o
n
 M
ay 22, 2015 by UNIVERSITY O
F SO
UTHAM
PTO
N HIG
HFIELD
http://m
cb.asm
.org/
D
ow
nloaded from
 
cancer cell survival at acidic pH over an extended time period,
we cultured A549 and HCT116 cells in medium buffered at
acidic pH (6.7) for approximately 3 months (denoted 6.7EXT).
As controls, cells were also maintained in medium buffered at
physiological pH (7.4) for the same period of time (denoted
7.4EXT). Interestingly, both eEF2K protein levels and eEF2
phosphorylation were lower in 6.7EXT cells than in 7.4EXT
cells (Fig. 11A and B), which correlated with an increase in the
sub-G1 population for 6.7EXT cells (Fig. 11C and D), suggest-
ing that decreased eEF2K expression and eEF2 phosphoryla-
tion may account for the impaired cell viability upon chronic
acidosis. Surprisingly, we found that 6.7EXT HCT116 cells
showed enhanced mTORC1 signaling (Fig. 11A and B). This
may be an acquired adaptive mechanism to help maintain cell
growth and proliferation under chronic acidosis.
Because shRNA knockdown of eEF2K is incomplete in 6.7EXT
FIG 7 Histidine residues within the ATP-binding site of eEF2K (light gray) andMHCKA (dark gray) are required for eEF2K activation under low pH. (A) Front
view of superimposed homologymodel of eEF2K and the structure ofMHCKA (PDB code 3LKH); histidines (H227 andH230) andATP are shown as sticks. (B)
Sequence alignment of eEF2K ATP-binding region among species. (C) eEF2K assay using MH-1 with either wild-type eEF2K or the H227A or H230Amutants.
(D) eEF2K assay with wild-type eEF2K, eEF2K(H227A/H230A), or eEF2K(H227K/H230K). Results in panels C, D, and E are expressed as means	 SE from 3
independent experiments. *, 0.01 P
 0.05; #, 0.01
 P 0.001; $, P
 0.001. (E) ATP binding of eEF2Kmutants was determined by UV cross-linking using
[-32P]ATP. Data shown are representative of three independent experiments.
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FIG 8 CaM H108 is essential for eEF2K activation. (A) Ribbon diagram of the closed CaM structure (PDB code 1CDL). The histidine (H108) and residues
coordinating the Ca2 ions are shown as sticks, and the Ca2 ion is shown as a sphere. (B) Sequence alignment of CaM(110–120) among species. (C) eEF2K
kinase assay usingwild-typeCaMor theH108AorH108Kmutant ofCaMat pH6.9 andpH7.4. (D)Calorimetric titrations ofCaMmutantswith eEF2K(78–100)
at pH6.8. eEF2K(78–100) peptide corresponds to the sequence of theCaM-binding site in eEF2K(78–100).P valueswere obtained by two-wayANOVA followed
by Dunnett’s test (control, pH 6.9, wild-type eEF2K). (E) CaMK1 activity assay at pH 6.8 with the indicated amount of CaM per assay. (F) CaMK1 activity assay
using 16 g of wild-type CaM of the H108A or H108Kmutant of CaM at pH 6.9 and pH 7.4. Results are expressed as means	 SE from 3 (in panels C and E) or
4 (in panel F) independent experiments. *, 0.01 P
 0.05; #, 0.01
 P 0.001; $, P
 0.001. For data in panel F, P values were obtained by two-way ANOVA
followed by Dunnett’s test (control, pH 6.9, wild-type eEF2K and wild-type CaM).
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FIG 9 Acidosis activates eEF2K in cancer cells. (A) Validation of the P-eEF2 Thr56 antibody for immunohistochemistry. eEF2KWT and knockout (KO)MEFs
were stained with P-eEF2 Thr56. Scale bar, 50 m. (B) Representative sequential sections of human lung cancer to support expression of NHE-1, GLUT-1, and
P-eEF2 Thr56. Nuclei were counterstained with hematoxylin. Ten lung cancer carcinoma samples were stained in total, 7 of which showed strong areas of
GLUT-1 expression; of these, 6 codisplayed NHE-1 and P-eEF2 Thr56. Scale bar, 100 m. A549 (C) or HCT116 (D) cells were cultured in medium buffered at
pH 6.4, 6.8, or 7.4 for the indicated times. IPTG (1 M) was added to A549 (E) or HCT116 (F) cells 5 days before the experiment. Cells were then incubated in
mediumbuffered at different pH values for 48 hwith/without 1mM IPTG, 30MA484954, or 25Metoposide, followed by lysis andWestern blot analysis. (G)
A549 cells were treated as described for panel E, and Western blot analysis was then performed to study the phosphorylation of p70S6K1 at Thr389 and S6 at
Ser240/Ser244. For panels C to G, data shown are representative of three independent experiments.
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FIG 10 Activation of eEF2K is important in cancer cell survival under acute acidic conditions. A549 (A) or HCT116 (B) cells were treated as described for Fig.
9E and F, respectively, and then subjected to cell ATP assay using the CellTitre-Glo kit. A549 (C) or HCT116 (E) cells were treated as described for panels A and
B, respectively, and then subjected to cytotoxicity assay using CellTox Green kit. A549 (D) or HCT116 (F) cells were cultured as described for panels A and B,
respectively, and then subjected to flow cytometry analysis. The percentage of sub-G1 population is presented. For panels A, B, C, and E, results are
expressed as means	 SE from 3 independent experiments in duplicate. For panel D, results are means	 SE from 3 independent experiments. For panel
E, results are means	 SE from 2 independent experiments and a third one in duplicate. P values were obtained either by two-way ANOVA (*, 0.01 P

0.05; **, 0.01 
 P  0.001; ***, P 
 0.001) or by one-way ANOVA followed by Dunnett’s test (@, 0.01  P 
 0.05; #, 0.01 
 P  0.001; $, P 
 0.001).
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HCT116 cells, we also treated HCT116 cells expressing shRNA
against eEF2K with A484954, a selective eEF2K inhibitor (39).
This completely abolished the acidosis-induced eEF2 phosphory-
lation (Fig. 11B). At pH 7.4, A484954 plus IPTG did not affect cell
size (Fig. 11E) or cell viability (Fig. 11F), indicating that it is not
toxic to cells maintained at physiological pH. Importantly,
knockdown of eEF2K by inducible shRNA concomitant with its
inhibition by A484954 in 6.7EXT HCT116 cells, which did not
FIG 11 The role of eEF2K in cancer cell survival under chronic extracellular acidosis. A549 (A) or HCT116 (B) cells were cultured in pH 6.7 (6.7EXT) or pH 7.4
(7.4EXT) buffered medium for about 3 months. Cells were then cultured in pH 6.7 or 7.4-buffered media for 48 h with/without 1 mM IPTG and/or 30 M
A484954, before lysis and Western blot analysis. A549 (C) or HCT116 (D, G) cells were also subjected to flow cytometry to determine subG1 population. (E)
HCT116 cells were cultured at pH 7.4 in the presence or absence of 1 mM IPTG and 30 M A484954 for 48 h, and G1 cell size was then determined by flow
cytometry. Results are shown as forward scatter-height (FSC-H). (F) HCT116 cells were cultured as described for panel E and then subjected to flow cytometry
analysis; the percentage of sub-G1 population is shown. (H) HCT116 cells cultured at pH 6.7 (6.7EXT) or 7.4 (7.4EXT) for approximately 3 months were
transfected with GFP-spectrin alone or GFP-spectrin plus FLAG-tagged eEF2K as indicated. Cells were lysed 8 h after transfection, and eEF2K levels were
analyzed byWestern blotting.Data are expressed asmean	 SE from3 independent experiments.P valueswere obtained by two-wayANOVA. *, 0.01P
 0.05;
**, 0.01
 P 0.001; ***, P
 0.001. For panels A and B, data shown are representative of three independent experiments.
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alter mTORC1 activation (Fig. 11B), further enhanced acido-
sis-induced cell death (Fig. 11G). We have also tried to express
eEF2K exogenously to test whether this would rescue acidosis-
induced cell death; GFP-spectrin was coexpressed with eEF2K
to select transfected cells by flow cytometry. However, it was
not feasible to express exogenous eEF2K in cells cultured under
acidic conditions, because exogenous wild-type eEF2K is de-
graded during acidosis (Fig. 11H), and to date, we have not
identified a nondegradable mutant of eEF2K that is also active
(further supporting the conclusion that the pH-induced deg-
radation of eEF2K requires its activity). Nevertheless, the data
strongly suggest that the levels of eEF2K expression and eEF2
phosphorylation dictate the survival rates of cancer cells in
acidic environments.
eEF2K suppresses protein synthesis at low pH. It has previ-
ously been shown that overexpressing eEF2K in 3T3 fibroblasts
suppresses protein synthesis at pH 6.4 but not pH 7.4 (19). How-
ever, it was not known whether endogenous eEF2K regulates pro-
tein synthesis at lowpH.To investigate this, we culturedA549 cells
in methionine-free medium buffered at different pHs (6.2 to 7.4),
to allow us to use the incorporation of [35S]methionine to mea-
sure protein synthesis. As expected (5), acidic conditions led to a
reduction in protein synthesis. Protein synthesis was faster in cells
where eEF2K had been knocked down than in the control cells
(Fig. 12A), and the effect of eEF2K knockdown on the enhance-
ment of protein synthesis was greater when cells were cultured at
acidic pH (Fig. 12B), suggesting that eEF2K plays a greater role in
limiting protein synthesis at low pH than at physiological pH
(consistent with its activation at low pH). We also analyzed ribo-
some distribution in A549 during acidosis (pH 6.7) versus physi-
ological conditions (pH 7.4). We observed an increase in transla-
tionally inactive monosomal fractions and a concomitant
decrease in translationally active polysomal fractions in both con-
trol and eEF2K knockdown cells incubated at pH 6.7 compared to
those maintained at pH 7.4 (Fig. 12C), indicative of impaired
initiation. However, strikingly, at pH 6.7 the proportion of sub-
polysomal material was markedly greater in eEF2K knockdown
cells than controls. This likely reflects faster translation elongation
FIG 12 The role of eEF2K in protein synthesis under acidosis. (A) IPTG (1 M) was added to A549 cells 5 days before experiment. A549 cells were then
transferred to media at different pH values for 1 h with/without 1M IPTG. Rates of protein synthesis were determined, and results are presented as counts per
minute (cpm) per microgram protein and expressed as means	 SE from 4 independent experiments. (B) Quantification of IPTG-treated cells as described for
panel A expressed as a percentage of control (no IPTG treatment). For panels A and B, P values were obtained either by two-way ANOVA (*, 0.01 P
 0.05;
**, 0.01
 P 0.001; ***, P
 0.001) or by one-way ANOVA followed by Dunnett’s test (@, 0.01 P
 0.05; #, 0.01
 P 0.001; $, P
 0.001). (C) A549 cells
were incubated at pH6.7 or 7.4 for 1 h. Lysateswere fractionated on sucrose density gradients. Positions of the 40S, 60S, and 80S ribosomal particles andpolysome
fractions are shown. Absorbance values (254 nm) are in arbitrary units and on the same scale for each panel. Representative data from4 independent experiments
are shown.
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in the knockdown cells, due to low levels of eEF2 phosphorylation,
leading to ribosomal “runoff” and loss of polysomes. This illus-
trates that eEF2K normally restrains elongation, especially at low
pH. The relatively higher rates of protein synthesis in eEF2K
knockdown cells may account for the higher consumption of en-
ergy at acidic pH, resulting in impaired cell viability.
DISCUSSION
Here we show that eEF2K is rapidly activated in response to
acidosis in cells, an effect that is followed by its downregula-
tion. To our knowledge, eEF2K is the first protein kinase
known to be strongly activated by low pH in vitro (19). How-
ever, previous to this study, it was not known how eEF2K is
activated under acidosis in vivo, and in particular, the physio-
logical or pathological roles of this activation were also unclear.
Importantly, we show that eEF2K contributes to cancer cell
survival under acidic conditions, potentially providing a ther-
apeutic target for treatment of solid tumors that are sur-
rounded by acidic pH (Fig. 13).
It has previously been shown that mTORC1 activity can be
inhibited by extracellular acidosis and that this can be dependent
or independent of TSC1/2 (5, 29). Here we have demonstrated
that the intrinsic kinase activity of mTORC1 is itself decreased at
acidic pH. Since mTORC1 signaling promotes anabolism, this
effect is physiologically sensible, as it will act to slow down anab-
olismprocesses under adverse conditions associatedwith acidosis.
mTORC1 promotes the phosphorylation of eEF2K on at least 7 sites
(16), leading to its inactivation. Release of this negative input at
acidic pH could provide a mechanism for activation of eEF2K
under such conditions. However, inhibition of mTORC1 was
unlikely to be the main cause of the activation of eEF2K by
acidic pH, because (i) the levels of eEF2 phosphorylation in-
duced by acidosis in cells were much higher than in rapamycin-
treated cells (Fig. 1A) and (ii) in TSC2-null cells, where
mTORC1 signaling is hyperactivated, eEF2 phosphorylation
remained sensitive to changes in extracellular pH (Fig. 3B),
although the levels of eEF2 phosphorylation are lower in such
cells, presumably due to lower eEF2K expression and/or re-
pression of eEF2K activity (Fig. 3B).
Thus, given earlier findings (19) and the data reported here, the
activity of eEF2K appeared to be controlled directly by pH in cells.
This could reflect the protonation of certain amino acid side
chains in eEF2K (19, 26). Histidine is the only amino acid whose
side chain normally has a pKa within this range. The affinity of
eEF2K for CaM has been shown to be enhanced at low pH (26).
Here we identify 3 histidines (H80, H87, and H94) in the CaM-
binding domain of eEF2K and two more (H227 and H230) in the
ATP-binding region of eEF2K, all of which play important roles in
the activation of eEF2K at low pH. We also show that the sole
histidine residue in CaM (H108) is crucial for eEF2K activation at
both acidic and physiological pH. These histidines in eEF2K are
not conserved in other -kinases.
CaM binds up to four Ca2 ions, and H108 is located close to
one of the four Ca2-binding regions (Fig. 8A). Although it is
therefore possible that H108 plays a role in the binding of Ca2
to CaM, it is hard to explain why this mutation has no effect on
the activation of CaMK1 by CaM (Fig. 8F). Carbethoxylation of
CaM H108 does not affect CaM-mediated stimulation of cyclic
nucleotide phosphodiesterase (40). The regulation of eEF2K by
low pH involves two unusual effects: an enhancement of its
activation by CaM, which is not seen, e.g., for CaMK1, and
histidines in its catalytic domain, which are not conserved in
other -kinases.
Acidosis also leads to a reduction in eEF2K protein levels,
FIG 13 Schematic presentation of molecular mechanisms by which acidosis controls the mTORC1 and eEF2K pathway to shut down protein synthesis
and aid cancer cell survival. Arrows, positive effects or activation; solid “T” lines, inhibition; dotted “T” lines, inhibitory effect that is alleviated upon
upstream inhibition.
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which could result from downregulation of eEF2K mRNA levels
(Fig. 1G), increased degradation of the eEF2K protein, and/or,
perhaps, decreased translation of itsmRNA.While this decrease in
eEF2K levels may seem surprising when its activation aids cell
survival, excessive eEF2K activitymay be deleterious to cells in the
long term (for an example, see reference 41) and its decreased
expression may help maintain appropriate levels of eEF2 phos-
phorylation/elongation and/or allow cells subsequently to recover
from acidotic stress.
Acidification of the extracellular environment is an important
feature of malignant solid tumors and results from their prefer-
ence for anaerobic glycolysis (42) and poor vascularization. How-
ever, unlike peritumoral normal tissues, which are susceptible to
acidosis-induced cell death, tumor cells display resistance to acidic
cytotoxicity, favoring their invasion into the damaged adjacent
normal tissues (7). eEF2K is highly expressed and activated in
solid tumor cells (38). Extracellular acidity not only dictates can-
cer aggressiveness and promotes evasion of immune rejection but
also generates chemoresistance, because most cancer drugs are
mildly basic, and acidosis renders cancer cells less susceptible
to their cytotoxic effects upon their protonation at low pH
(43). Significant effort has been applied to study how to impair
tumor cell survival under acidic conditions, e.g., by neutraliz-
ing the acidic environment using agents such as bicarbonate, by
using proton pump inhibitors to reduce intracellular pH, or by
hyperacidification of the intra- and/or extracellular space (43).
Nevertheless, to our knowledge, prior to this study, no protein
kinase involved in cancer cell survival under acidosis had been
described.
The activities of mTORC1 and thus eEF2K are highly sensitive
to nutrient availability (25, 38). Notably, inhibition of mRNA
translation protects cancer cells from nutrient deprivation-in-
duced cell death (38, 44). Similarly, acidosis also suppresses
mRNA translation (5, 6), and this may also protect cells, by de-
creasing nutrient/energy demand. Here we provide evidence that
the activation of eEF2K plays a role in the adaptation of cancer
cells to acidic stress. The survival rates of tumor cells under aci-
dotic conditions depend on the activity and expression levels of
eEF2K. In keeping with this, stimulation of the AMPK-eEF2K
pathway and the subsequent inhibition of translation elongation
play crucial roles in cancer cell survival when nutrient availability
is compromised (38). Since acidosis is a consequence of altered
energy-generating metabolism, it is to be expected that highly en-
ergy-demanding cellular processes, such as protein synthesis, are
slowed down to save ATP and preserve energy balance under such
conditions. Indeed, knockdown of eEF2K increased protein syn-
thesis in cancer cells cultured at acidic pH (Fig. 12A and B). It is
therefore plausible that activation of eEF2K during acidosis slows
down protein synthesis to protect cancer cells from energy over-
consumption and consequent death. The activation of eEF2Kdur-
ing acidosis could also affect the translation of certain mRNAs
(45), whichmay include proapoptotic/necrotic factors or proteins
needed for cell adaptation to acidic stress (Fig. 13). The slowing
down of protein synthesis caused by the pH-dependent activation
of eEF2K may also be important in decreasing energy consump-
tion in other settings, such as tissue acidosis. We tried testing
whether using cycloheximide to restore elongation inhibition in
cells where eEF2K had been knocked down could rescue cell sur-
vival at acidic pH. However, cycloheximide further increased cell
death under all pH conditions tested (data not shown), in line
with several previous studies that showed that cycloheximide is
cytotoxic to a variety of cancer cells (46–49).
Hypoxia, anothermajor characteristic of solid tumors, has also
been shown to evoke tumor extracellular acidification (50). In
fact, it has previously been reported that eEF2K activation also
aids cancer cell survival under hypoxia (51).Moreover, high levels
of eEF2K expression correlate with the most aggressive subtype of
medulloblastoma and glioblastoma multiforme (38). Taken to-
gether, these data strongly support the development of anticancer
therapeutic strategies with eEF2K as a target.
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